SCNN1A and neuroblastoma: Current studies on ENaC in cancer have shown that in breast cancer and neuroblastoma, SCNN1A gene silencing caused by hypermethylation in the promoter region of the SCNN1A gene, which encodes the α subunit of ENaC, is the main reason for the poor prognosis of patients with these tumors and diseases.